Serglycin is an intracellular PG that aggregates with CD44 to promote lung cancer cell migration by triggering the CD44/NF-κB/CLDN1 [69] and CD44/Rho/Src/FAK axes [231]. Here, CD44 is linked to lung carcinoma.